These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 7264628)
1. Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides. Fuxe K; Agnati LF; Köhler C; Kuonen D; Ogren SO; Andersson K; Hökfelt T J Neural Transm; 1981; 51(1-2):3-37. PubMed ID: 7264628 [TBL] [Abstract][Full Text] [Related]
2. Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine. Camus A; Javoy-Agid F; Dubois A; Scatton B Brain Res; 1986 Jun; 375(1):135-49. PubMed ID: 3719352 [TBL] [Abstract][Full Text] [Related]
3. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates. Gundlach AL; Krstich M; Beart PM Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373 [TBL] [Abstract][Full Text] [Related]
4. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor. Battaglia G; Titeler M Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376 [TBL] [Abstract][Full Text] [Related]
5. Binding of antiparkinsonian ergot derivatives to the dopamine receptor. Weir RL; Hruska RE; Silbergeld EK Psychopharmacology (Berl); 1981; 75(2):119-23. PubMed ID: 6798600 [TBL] [Abstract][Full Text] [Related]
6. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
7. Chronic dihydroergotoxine treatment affects the number of dopamine recognition sites in rat striatum. Battaini F; Govoni S; Rius RA; Spano PF; Trabucchi M Pharmacol Res Commun; 1984 Jun; 16(6):605-11. PubMed ID: 6463097 [TBL] [Abstract][Full Text] [Related]
8. Interaction of pergolide with central dopaminergic receptors. Goldstein M; Lieberman A; Lew JY; Asano T; Rosenfeld MR; Makman MH Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3725-8. PubMed ID: 6932044 [TBL] [Abstract][Full Text] [Related]
9. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro. Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587 [TBL] [Abstract][Full Text] [Related]
10. Central monoamine synapses as sites of action for ergot drugs. Fuxe K; Ogren SO; Agnati LF; Andersson K; Hall H; Köhler C; Fredholm B Adv Biochem Psychopharmacol; 1980; 23():41-62. PubMed ID: 6104914 [TBL] [Abstract][Full Text] [Related]
11. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat. Hall MD; Jenner P; Kelly E; Marsden CD Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246 [TBL] [Abstract][Full Text] [Related]
12. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides. Fuxe K; Agnati LF; Benfenati F; Celani M; Zini I; Zoli M; Mutt V J Neural Transm Suppl; 1983; 18():165-79. PubMed ID: 6192208 [TBL] [Abstract][Full Text] [Related]
13. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists. Lehmann J; Briley M; Langer SZ Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762 [TBL] [Abstract][Full Text] [Related]
14. Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors. Köhler C; Fuxe K; Ross SB Eur J Pharmacol; 1981 Jul; 72(4):397-402. PubMed ID: 7274333 [TBL] [Abstract][Full Text] [Related]
15. In situ molecular size of agonist dopamine D-2 binding sites in rat striatum. Gredal O; Nielsen M J Neurochem; 1987 Feb; 48(2):364-9. PubMed ID: 3794711 [TBL] [Abstract][Full Text] [Related]
16. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats. Arnt J; Hyttel J Psychopharmacology (Berl); 1985; 85(3):346-52. PubMed ID: 2860689 [TBL] [Abstract][Full Text] [Related]
17. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors. Claustre Y; Fage D; Zivkovic B; Scatton B J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197 [TBL] [Abstract][Full Text] [Related]
18. Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites. Herrera-Marschitz M; Ungerstedt U Eur J Pharmacol; 1984 Feb; 98(2):165-76. PubMed ID: 6143675 [TBL] [Abstract][Full Text] [Related]
19. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525 [TBL] [Abstract][Full Text] [Related]
20. Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes. Srivastava LK; Bajwa SB; Johnson RL; Mishra RK J Neurochem; 1988 Mar; 50(3):960-8. PubMed ID: 2892892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]